1. Home
  2. BRCB vs CHRS Comparison

BRCB vs CHRS Comparison

Compare BRCB & CHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Black Rock Coffee Bar Inc.

BRCB

Black Rock Coffee Bar Inc.

N/A

Current Price

$10.59

Market Cap

179.2M

Sector

N/A

ML Signal

N/A

Logo Coherus BioSciences Inc.

CHRS

Coherus BioSciences Inc.

N/A

Current Price

$0.64

Market Cap

159.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BRCB
CHRS
Founded
2008
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
179.2M
159.1M
IPO Year
2025
2014

Fundamental Metrics

Financial Performance
Metric
BRCB
CHRS
Price
$10.59
$0.64
Analyst Decision
Buy
Buy
Analyst Count
8
6
Target Price
★ $11.71
$7.75
AVG Volume (30 Days)
523.4K
★ 1.6M
Earning Date
11-10-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 472.00
EPS
★ 0.08
N/A
Revenue
★ $200,321,000.00
N/A
Revenue This Year
$27.52
$34.69
Revenue Next Year
$24.44
$70.40
P/E Ratio
$138.63
★ N/A
Revenue Growth
★ 24.49
N/A
52 Week Low
$6.11
$0.73
52 Week High
$25.20
$2.62

Technical Indicators

Market Signals
Indicator
BRCB
CHRS
Relative Strength Index (RSI) 61.68 32.51
Support Level $6.68 N/A
Resistance Level $15.72 $1.53
Average True Range (ATR) 0.83 0.10
MACD 0.05 -0.02
Stochastic Oscillator 63.92 6.37

Price Performance

Historical Comparison
BRCB
CHRS

About BRCB Black Rock Coffee Bar Inc.

Black Rock Coffee Bar Inc is an operator of guest-centric, drive-thru coffee bars offering premium caffeinated beverages and an elevated in-store experience crafted by its engaging baristas. The company offers wide variety of coffee from classic espresso-based drinks such as Lattes, Americanos, and Cappuccinos, as well as signature creations like the Caramel Blondie, Mexican Mocha, and Blackout. It offers a variety of savory and sweet items, including breakfast burritos, sausage cheddar sandwiches, banana bread, and glazed donut holes.

About CHRS Coherus BioSciences Inc.

Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its portfolio includes LOQTORZI which was developed for its ability to block PD-1 interactions with its ligands, PD-L1 and PD-L2, by binding to the FG loop on the PD-1 receptor. Company believe blocking PD-1 interactions with PD-L1 and PD-L2 can help to promote the immune systems.

Share on Social Networks: